三苯氧胺对乳腺癌患者宫颈的影响(3)
 |
| 第1页 |
参见附件(1850KB，3页)。
13(6): 338-341.
[7]Friedrich M, Mink D, Herinsen C V, et al. Tamoxifen and proliferation of vaginal and cervical epithelium in postmenopausal women with breast cancer[J]. Eur J Obst Gyn Repro Biol, 1998,80: 221-225.
[8]Gill B L, Simpson J F, Somlo G, et al. Effects of tamoxifen on the cytology of the uterine cervix in breast cancer patients[J]. Diagn Cytopathol, 1998,19(6): 417-422.
[9]Yang Y J, Trapkin LK, Demoski R K, et al. The small blue cell dilemma associated with tamoxifen therapy[J]. Arch Pathol Lab Med, 2001,125: 1047-1050.
[10]江泽飞，宋三泰，孙燕. 乳腺内分泌治疗的基本原则和新动向——2006年美国NCCN乳腺内分泌治疗指南解读[J]. 临床药物治疗杂志，2006, 4(2): 21-25.
[11]Solomon D. The 2001 Bethesda System: Terminology for reporting results of cervical cytology[J]. JAMA, 2002, 287: 2114-2119.
[12]刘淑范.浅析巴氏五级分类法与TBS描述性诊断报告方式[J].中国实用妇科与产科杂志, 2003, 19(3): 135.
[13]江泽飞, 徐兵河, 宋三泰,等. 乳腺癌内分泌治疗的基本共识[J].中华肿瘤杂志, 2006, 28(3): 238-239.
[14]赵大伟, 蔡勇, 刘克,等. 乳腺癌内分泌治疗的现状及展望[J].实用肿瘤学杂志, 2005, 19(1): 77-80.
[15]Ross V, Weather, Scanlan T S. Unique protein determinants of the subtype-selective ligand responses of the estrogen receptors (ERα and ERβ) at AP-1 sites [J]. J Biol Chem, 2001,276: 3827-3832.
[16]邹自英，朱运龙，王高峰,等，三苯氧胺对乳腺癌和宫颈癌细胞增殖的影响[J]. 中国应用生理学杂志，2003，19(2)：189-192.
[17]Piura B，Inbar I Y，Aabinovich A，et al. Abnormal uterine bleeding as a presenting sign of metastases to the uterine corpus, cervix and vagina in a breast cancer patient on tamoxifen herapy[J]. Eur J Obst Gyn Repro Bio, 1999, 83: 57-61.
(收稿日期：2008-05-21)
注：本文中所涉及到的图表、注解、公式等内容请以PDF格式阅读原文
您现在查看是摘要介绍页，详见PDF附件(1850KB，3页)。